Results.
A total of 64 stool and rectal swab samples were collected from January 16 to January 27, 2009. V cholerae O1 was isolated in 38 samples (59%). All isolates belonged to the El Tor biotype; 31 and 7 isolates belonged to Ogawa and Inaba serotypes, respectively. Of the 38 isolates, 31 strains were available for further testing. Two distinct ribotype patterns (A and B) were observed among the isolates.
All strains were susceptible to azithromycin and tetracycline, with MIC 90 (MIC required to inhibit the growth of 90% of organisms) of 0.125 mg/L and 0.5 mg/L, respectively. The MIC 90 of ciprofloxacin was 0.5 mg/L, with a distinction between the ciprofloxacin susceptibility of ribotype A and ribotype B. The ciprofloxacin MIC of ribotype A ranged from 0.125 to 0.5 mg/L. The ciprofloxacin MIC of type B was 0.004 mg/L (FIGURE). Thus, the ciprofloxacin MICs of clonal type A were 30 to 125 times higher than those of clonal type B and within 1 to 3 two-fold dilutions of the susceptibility breakpoint of 1 mg/L. The strains of clone B were susceptible to nalidixic acid by disk diffusion, but clone A strains were resistant. All strains were resistant to furazolidone and trimethoprim-sulfamethoxazole.
Comment. To our knowledge, this is the first description of an outbreak of cholera with reduced susceptibility against fluoroquinolones on the African continent. Nalidixic acid resistance has been reported in Ghana and Mozambique, but no quantitative susceptibility tests or MICs were performed and no resistance to fluoroquinolones was detected. 4 Ciprofloxacin resistance may be associated with progressive multiple mutations in the gyrA gene 5 ; nalidixic acid resistance may therefore have facilitated the emergence of resistance to the fluoroquinolones. Reduced susceptibility of V cholerae against ciprofloxacin (MIC, 0.25 mg/L) has been reported previously in patients hospitalized in Bangladesh and was associated with therapy failure in these patients. 6 The reported reduced susceptibility is therefore reason for concern.
Antimicrobial susceptibility is often not determined in cholera, and qualitative antimicrobial susceptibility tests (eg, The measured minimum inhibitory concentrations were rounded to the nearest higher 2-fold dilution.
disk diffusion) may fail to detect strains with reduced susceptibility. Longitudinal surveillance of antimicrobial susceptibility of V cholerae O1 using quantitative (MIC) methods is therefore recommended for early detection of emergence of resistance. :1301-1308), the column headings for "Men" and "Women" in Table 3 on page 1306 were inverted. 
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